{"id":"https://openalex.org/W1896634820","doi":"https://doi.org/10.1634/theoncologist.7-suppl_4-9","title":"ZD1839 (Iressa\u2122) in Non-Small Cell Lung Cancer","display_name":"ZD1839 (Iressa\u2122) in Non-Small Cell Lung Cancer","publication_year":2002,"publication_date":"2002-08-15","ids":{"openalex":"https://openalex.org/W1896634820","doi":"https://doi.org/10.1634/theoncologist.7-suppl_4-9","mag":"1896634820","pmid":"https://pubmed.ncbi.nlm.nih.gov/12202783"},"language":"en","primary_location":{"id":"doi:10.1634/theoncologist.7-suppl_4-9","doi":"https://doi.org/10.1634/theoncologist.7-suppl_4-9","is_oa":false,"landing_page_url":"https://doi.org/10.1634/theoncologist.7-suppl_4-9","pdf_url":null,"source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008593691","display_name":"Roy S. Herbst","orcid":"https://orcid.org/0000-0003-2535-5847","observed_orcids":["https://orcid.org/0000-0003-2535-5847"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Roy S. Herbst","raw_affiliation_strings":["Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109183518","display_name":"Merrill S. Kies","orcid":"https://orcid.org/0009-0001-8711-1699","observed_orcids":["https://orcid.org/0009-0001-8711-1699"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Merrill S. Kies","raw_affiliation_strings":["Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5008593691"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":3852,"currency":"USD","value_usd":3852},"apc_paid":null,"fwci":8.7363,"has_fulltext":false,"cited_by_count":58,"citation_normalized_percentile":{"value":0.98047572,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"S4","first_page":"9","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.972000002861023},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9599999785423279},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9430000185966492},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.5669999718666077},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cancer-prevention","display_name":"cancer prevention","score":0.8399999737739563},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5249999761581421},{"id":"https://openalex.org/keywords/cisplatin-based-chemotherapy","display_name":"cisplatin-based chemotherapy","score":0.859000027179718}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9029706120491028},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.6981289386749268},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6735841035842896},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6148507595062256},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.602218508720398},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5713576674461365},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5336858034133911},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4926822781562805},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4279957115650177},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38361918926239014},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14106619358062744}],"mesh":[{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1634/theoncologist.7-suppl_4-9","doi":"https://doi.org/10.1634/theoncologist.7-suppl_4-9","is_oa":false,"landing_page_url":"https://doi.org/10.1634/theoncologist.7-suppl_4-9","pdf_url":null,"source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},{"id":"pmid:12202783","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12202783","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The oncologist","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W141806765","https://openalex.org/W1653571790","https://openalex.org/W1659692600","https://openalex.org/W1839238860","https://openalex.org/W1935885922","https://openalex.org/W1964980047","https://openalex.org/W1985153867","https://openalex.org/W2019995422","https://openalex.org/W2037139573","https://openalex.org/W2130652363","https://openalex.org/W2135422811","https://openalex.org/W2151220251","https://openalex.org/W2163252214","https://openalex.org/W2163402367","https://openalex.org/W2167368130","https://openalex.org/W2169332099","https://openalex.org/W2231156824","https://openalex.org/W2255384265","https://openalex.org/W2770088563","https://openalex.org/W4239714259","https://openalex.org/W6636784571","https://openalex.org/W6692096254"],"related_works":["https://openalex.org/W2338384653","https://openalex.org/W2289539853","https://openalex.org/W2087979273","https://openalex.org/W2499874848","https://openalex.org/W1971828243","https://openalex.org/W2049938167","https://openalex.org/W1995283055","https://openalex.org/W2255384265","https://openalex.org/W4234648148","https://openalex.org/W1985153867"],"abstract_inverted_index":{"Abstract":[0],"Learning":[1],"Objectives":[2],"After":[3],"completing":[4],"this":[5,90],"course,":[6],"the":[7,13,31,57,74,87,103,135,147,154,160,166,171],"reader":[8],"will":[9],"be":[10],"able":[11],"to:Identify":[12],"current":[14],"status":[15],"of":[16,23,65,76,153,168,173],"Phase":[17],"I,":[18],"II,":[19],"and":[20,42,55,61,110,134],"III":[21],"trials":[22],"ZD1839":[24,36,143,169],"in":[25,37,44,100,150,170],"non-small":[26,82],"cell":[27,83],"lung":[28,84],"cancer":[29,85],"(NSCLC).Describe":[30],"clinical":[32,151,163],"development":[33,101,152],"plan":[34],"for":[35,50,80,89,105],"second":[38],"line,":[39],"adjuvant":[40],"(maintenance),":[41],"prevention":[43],"patients":[45,51],"with":[46,52,117],"NSCLC.Identify":[47],"treatment":[48,172],"options":[49],"NSCLC.":[53,174],"Access":[54],"take":[56],"CME":[58],"test":[59],"online":[60],"receive":[62],"one":[63],"hour":[64],"AMA":[66],"PRA":[67],"category":[68],"1":[69],"credit":[70],"at":[71],"CME.TheOncologist.com":[72],"Despite":[73],"advent":[75],"cisplatin-based":[77],"combination":[78],"chemotherapy":[79],"advanced":[81],"(NSCLC),":[86],"prognosis":[88],"patient":[91],"population":[92],"remains":[93],"poor.":[94],"Novel":[95],"biologically":[96],"targeted":[97],"agents":[98],"currently":[99,146,161],"have":[102],"potential":[104],"greater":[106],"efficacy":[107],"against":[108],"NSCLC,":[109],"possibly":[111],"less":[112],"toxicity":[113],"than":[114],"is":[115,127,145],"associated":[116],"conventional":[118],"cytotoxic":[119],"chemotherapy.":[120],"The":[121],"epidermal":[122],"growth":[123],"factor":[124],"receptor":[125],"(EGFR)":[126],"recognized":[128],"as":[129],"a":[130],"potentially":[131],"useful":[132],"target,":[133],"small":[136],"molecule,":[137],"orally":[138],"active":[139],"EGFR-tyrosine":[140],"kinase":[141],"inhibitor":[142],"(Iressa\u2122)":[144],"furthest":[148],"along":[149],"anti-EGFR":[155],"agents.":[156],"This":[157],"review":[158],"summarizes":[159],"available":[162],"data":[164],"on":[165],"use":[167]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}